glucagon has been researched along with suvorexant in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (suvorexant) | Trials (suvorexant) | Recent Studies (post-2010) (suvorexant) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 214 | 47 | 200 |
| Protein | Taxonomy | glucagon (IC50) | suvorexant (IC50) |
|---|---|---|---|
| Orexin receptor type 1 | Homo sapiens (human) | 0.0873 | |
| Orexin receptor type 2 | Homo sapiens (human) | 0.0613 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, Y; Ito, H; Kon, K; Sakurai, T; Sasahara, M; Sasaoka, T; Takahara, S; Toyooka, N; Tsuneki, H; Wada, T; Yamazaki, M; Yanagisawa, M | 1 |
1 other study(ies) available for glucagon and suvorexant
| Article | Year |
|---|---|
Timed Inhibition of Orexin System by Suvorexant Improved Sleep and Glucose Metabolism in Type 2 Diabetic db/db Mice.
Topics: Adipose Tissue; Animals; Azepines; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Energy Metabolism; Glucagon; Glucose; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Orexin Receptor Antagonists; Orexins; Receptors, Leptin; Sleep; Triazoles; Triglycerides; Wakefulness | 2016 |